You are here

Home

Clinical Trials: Musculoskeletal Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, September 2, 2021 - 12:00
Cell Therapy for IBM by Muscle Injection of ADSVF: a Phase I Trial
Condition:   Inclusion Body Myositis
Intervention:   Biological: ADSVF
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Monday, August 30, 2021 - 12:00
Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)
Condition:   Osteoarthritis, Knee
Interventions:   Drug: Bone marrow mesenchymal stem cells;   Drug: hyaluronic acid
Sponsors:   Taiwan Bio Therapeutics Co., Ltd.;   A2 Healthcare Taiwan Corporation
Not yet recruiting
Posted: Monday, August 23, 2021 - 12:00
Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury
Condition:   Osteoarthritis, Knee
Interventions:   Biological: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs);   Procedure: Marrow cellution
Sponsors:   Cytopeutics Sdn. Bhd.;   Universiti Kebangsaan Malaysia Medical Centre
Recruiting
Posted: Wednesday, August 11, 2021 - 12:00
Clinical Study of Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Knee Osteoarthritis
Condition:   Knee Osteoarthritis
Interventions:   Other: normal saline;   Other: Cord Blood Mononuclear Cells (UCB-MNCs)
Sponsor:   Lili Cao
Recruiting
Posted: Tuesday, August 10, 2021 - 12:00
Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting
Conditions:   Bone Loss, Osteoclastic;   Bone Loss, Alveolar;   Alveolar Bone Loss;   Alveolar Bone Atrophy;   Grafting Bone
Intervention:   Procedure: Maxillary sinus floor elevation grafting with synthetic bone substitute.
Sponsors:   Pontificia Universidade Católica do Rio Grande do Sul;   ITI International Team for Implantology, Switzerland;   KU Leuven;   Rio Grande do Sul Brain Institute (InsCer)
Not yet recruiting
Posted: Wednesday, August 4, 2021 - 12:00
Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis
Condition:   Hip Osteoarthritis
Interventions:   Combination Product: Emcyte PureBMC;   Drug: Triamcinolone
Sponsors:   The Cleveland Clinic;   Lisa Dean Moseley Foundation
Not yet recruiting
Posted: Monday, July 26, 2021 - 12:00
Evaluate the Safety, Tolerability and Efficacy of PN-101 in Patients With Refractory Polymyositis or Dermatomyositis
Conditions:   Polymyositis;   Dermatomyositis
Intervention:   Biological: PN-101
Sponsor:   Paean Biotechnology Inc.
Not yet recruiting
Posted: Friday, July 23, 2021 - 12:00
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
Condition:   Inclusion Body Myositis
Intervention:   Device: Adipose Derived Regenerative Cells
Sponsor:   University of Kansas Medical Center
Not yet recruiting
Posted: Wednesday, July 21, 2021 - 12:00
Alveolar Ridge Augmentation With Curcumin Combined With Xenograft
Condition:   Horizontal Alveolar Bone Loss
Intervention:   Drug: Curcumin
Sponsor:   Ain Shams University
Not yet recruiting
Posted: Wednesday, July 21, 2021 - 12:00
Cell-free Stem Cell-derived Extract Formulation for Knee Osteoarthritis
Condition:   Osteoarthritis, Knee
Intervention:   Biological: Cell-free Stem Cell-derived Extract Formulation (CCM)
Sponsor:   General Therapeutics
Not yet recruiting

Pages